导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.34% | 791/1050 |
| 近一周 | -5.19% | 1076/1104 |
| 近一月 | -1.44% | 183/1102 |
| 近一季 | -2.57% | 350/1092 |
| 近半年 | -14.73% | 885/1070 |
| 近一年 | -7.34% | 700/1018 |
| 近两年 | 28.19% | 695/926 |
| 近三年 | -0.53% | 682/834 |
| 成立以来 | 103.47% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.66% 436/1070 |
-10.13% 916/1101 |
- - |
- - |
| 2025 | 17.78% 704/1065 |
-0.09% 801/1014 |
5.49% 270/1038 |
7.79% 882/1050 |
3.68% 209/1065 |
| 2024 | -3.35% 660/1011 |
-3.58% 509/960 |
-5.88% 684/983 |
12.57% 412/991 |
-5.39% 691/1011 |
| 2023 | -24.12% 761/952 |
-4.07% 775/880 |
-11.38% 798/895 |
-6.81% 415/915 |
-4.23% 424/952 |
| 2022 | -12.10% 119/867 |
-4.09% 25/773 |
3.62% 598/806 |
-10.24% 254/845 |
-1.47% 511/867 |
| 2021 | -1.81% 379/740 |
-3.90% 301/580 |
-2.01% 563/659 |
-2.05% 256/704 |
6.45% 163/740 |
| 2020 | 53.14% 225/554 |
11.70% 36/419 |
15.01% 352/466 |
11.46% 218/517 |
6.95% 406/554 |
| 2019 | 70.40% 41/410 |
31.86% 270/1146 |
4.36% 59/1228 |
12.17% 75/390 |
10.39% 152/410 |
| 2018 | -11.30% 13/349 |
- - |
-4.69% 177/990 |
-0.96% 230/1000 |
-5.26% 58/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国泰大农业股票A VS. 东吴新产业精选股票A(580008) |